Chennai Antiviral Research and Treatment Symposium (CART) 2025
The Chennai Antiviral Research and Treatment Symposium (CART) 2025 is a highly specialized medical conference focused on the latest advancements in antiviral research and treatment strategies, particularly concerning HIV, Hepatitis B, Hepatitis C, and Tuberculosis. Organized by Academic Medical Education (AME), CART 2025 aims to bring together leading experts, researchers, and clinicians to exchange knowledge, discuss new data, and explore how the latest research findings can be translated into improved patient care, especially in the context of Southern Asia.
Key Topics and Agenda Highlights: The symposium will cover a range of critical subjects, including:
Convention Venue & Event Location
Official host facility & physical location
Chennai, India
Highlights
- 100,000+ On-site visits across 3 exhibition days.
- 100 onsite eventsoffering a complex platform for exhibition, competition, conference, demo & bazaar.
- Popular among visitors for:Top 100 in Trade & Industry in IndiaQuality of Participants & Buyers
Connect with real trade buyers, followers, and exhibitors registered for this edition.
Subject to organiser confirmation
Based on past verified edition statistics
B2B Trade Buyers & Corporate Delegations
Featured Exhibitor Directory
Explore participating companies, brands, and stall locations.
Unlock All 250+ Exhibitors & Booth Rep Phone Numbers
Access stall floorplans, downloadable product catalogs, and direct contact details with a free VisitExpo account.
Don't go alone! 0 attendees are interested — find your event partner!
Skip Hype. Only Real Demand & Confirmed Attendees.
VisitExpo Official Pass Guarantee
Registered attendees receive a verified digital QR pass compatible with fast-track entry kiosks at Chennai.
Show ConcludedPast ShowConnect with our concierge for bulk tickets, exhibitor stall pricing, or accommodation discounts.
Similar & Recommended Exhibitions
Curated expos matching Healthcare & Pharma and upcoming trade shows near Chennai.

